Core Viewpoint - The stock of Opcon Vision has shown fluctuations in recent trading days, with a slight increase on September 30, 2023, despite a year-to-date decline of 9.11% [1][2]. Company Overview - Opcon Vision Technology Co., Ltd. was established on October 26, 2000, and went public on January 17, 2017. The company is located in Hefei, Anhui Province, and specializes in the research, production, and sales of optical products and related services [2]. - The main revenue sources for the company include: hard contact lenses (40.86%), other optical products and technical services (21.52%), medical services (19.89%), nursing products (12.57%), non-optical products (4.60%), and other (0.55%) [2]. Financial Performance - For the first half of 2025, Opcon Vision reported a revenue of 871 million yuan, a year-on-year decrease of 1.42%, and a net profit attributable to shareholders of 250 million yuan, down 22.93% year-on-year [2]. - Since its A-share listing, the company has distributed a total of 897 million yuan in dividends, with 526 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for Opcon Vision was 61,000, a decrease of 1.56% from the previous period. The average circulating shares per person increased by 1.58% to 10,957 shares [2]. - Major institutional shareholders include Huabao Zhongzheng Medical ETF, Yifangda Growth Enterprise Board ETF, and Southern Zhongzheng 500 ETF, with all showing increases in their holdings compared to the previous period [3].

Company Overview - Opcon Vision, established on October 26, 2000, and listed on January 17, 2017, is located in Hefei, Anhui Province. The company specializes in the research, production, and sales of optical products and related services [1][2]. Financial Performance - For the first half of 2025, Opcon Vision reported a revenue of 871 million yuan, a year-on-year decrease of 1.42%, and a net profit attributable to shareholders of 250 million yuan, down 22.93% year-on-year [2]. - The company has distributed a total of 897 million yuan in dividends since its A-share listing, with 526 million yuan distributed over the past three years [3]. Stock Performance - As of September 11, Opcon Vision's stock price increased by 2.03% to 18.11 yuan per share, with a trading volume of 128 million yuan and a turnover rate of 1.07%, resulting in a total market capitalization of 16.229 billion yuan [1]. - Year-to-date, the stock price has decreased by 3.29%, with a 3.72% increase over the last five trading days, a 2.42% decrease over the last 20 days, and a 23.37% increase over the last 60 days [1]. Shareholder Structure - As of August 29, the number of shareholders for Opcon Vision was 61,700, a decrease of 3.70% from the previous period, with an average of 10,832 circulating shares per shareholder, an increase of 3.84% [2]. - The top ten circulating shareholders include significant institutional investors, with notable increases in holdings from various ETFs [3].

Core Viewpoint - The stock price of Opcon Vision has shown fluctuations, with a slight increase on September 8, 2023, but a decline in the year-to-date performance, indicating potential concerns regarding its market position and financial health [1][2]. Company Overview - Opcon Vision Technology Co., Ltd. was established on October 26, 2000, and listed on January 17, 2017. The company specializes in the research, production, and sales of optical products and related services [2]. - The company's revenue composition includes: hard contact lenses (40.86%), other optical products and technical services (21.52%), medical services (19.89%), nursing products (12.57%), non-optical products (4.60%), and other (0.55%) [2]. Financial Performance - For the first half of 2025, Opcon Vision reported a revenue of 871 million yuan, a year-on-year decrease of 1.42%, and a net profit attributable to shareholders of 250 million yuan, down 22.93% year-on-year [2]. - Since its A-share listing, the company has distributed a total of 897 million yuan in dividends, with 526 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for Opcon Vision was 61,700, a decrease of 3.70% from the previous period, with an average of 10,832 circulating shares per person, an increase of 3.84% [2]. - Major institutional shareholders include Huabao Zhongzheng Medical ETF, Yifangda Growth Enterprise Board ETF, and Southern Zhongzheng 500 ETF, all of which have increased their holdings compared to the previous period [3].

Core Viewpoint - Oupeng Vision's stock has experienced a decline in recent trading sessions, with a year-to-date drop of 5.59% and a 4.02% decrease over the last five trading days [1] Financial Performance - For the first half of 2025, Oupeng Vision reported revenue of 871 million yuan, a year-on-year decrease of 1.42%, and a net profit attributable to shareholders of 250 million yuan, down 22.93% year-on-year [2] - The company has distributed a total of 897 million yuan in dividends since its A-share listing, with 526 million yuan distributed over the past three years [3] Shareholder Information - As of August 29, 2025, the number of shareholders for Oupeng Vision was 61,700, a decrease of 3.70% from the previous period, while the average circulating shares per person increased by 3.84% to 10,832 shares [2] - Major institutional shareholders include Huabao Zhongzheng Medical ETF, Yifangda Growth Enterprise Board ETF, and Southern Zhongzheng 500 ETF, all of which have increased their holdings compared to the previous period [3] Market Activity - On September 3, Oupeng Vision's stock price was 17.68 yuan per share, with a trading volume of 72.59 million yuan and a turnover rate of 0.61% [1] - The company experienced a net outflow of 6.13 million yuan in principal funds, with significant selling pressure observed [1]

Core Viewpoint - The company held an online earnings briefing on September 2, 2025, to discuss its business development and engage with investors [1] Business Development Disclosure - The company started selling scleral lenses in March, which accounted for 0.6% of lens orders in the first half of the year, primarily targeting adult users and is in the initial promotion phase [1] - The ordinary soft lenses from Multi-vision Medical did not have sales in the first half but are set to be launched in the second half of the year [1] - The company completed industrial changes for Shangyue Qicheng in mid-August and will officially consolidate its financials in September, with current operations reported as good [1] Business Expansion - The company is expanding its service terminal business by enhancing both the content and scale, including the introduction of functional vision correction products, dry eye and visual fatigue solutions, and visual function training [2] - The sales department is being optimized with additional technical support and sales personnel in various regions, and a second distribution center has been established for hard lens sales [2] Collaboration and Capacity Planning - The company has partnered with numerous optical professional universities for talent development and technical research, allowing students to gain practical experience [3] - New production capacity for BFS sterile instruments and clean rooms has been established, with BFS production lines already producing disposable rinsing solutions and eye wash solutions [3] Other Key Points - In the first half of the year, revenue from rigid contact lens products accounted for 57.77% of total revenue, down from 62.06% in the same period last year [4] - The company has different management approaches for subsidiaries based on direct operations and minority shareholder operations [4] - Revenue from medical institutions has declined due to the cessation of atropine sales at the headquarters hospital, with some medical institution business downturns requiring further monitoring [4]

Core Viewpoint - The stock of Opcon Vision has shown fluctuations with a slight increase of 2.05% on September 1, 2023, while facing a year-to-date decline of 1.63% and a recent drop over the last five trading days of 3.96% [1] Financial Performance - For the first half of 2025, Opcon Vision reported a revenue of 871 million yuan, representing a year-on-year decrease of 1.42%, and a net profit attributable to shareholders of 250 million yuan, down 22.93% year-on-year [2] - The company has distributed a total of 897 million yuan in dividends since its A-share listing, with 526 million yuan distributed over the past three years [3] Shareholder Information - As of August 20, 2025, the number of shareholders for Opcon Vision was 64,100, a decrease of 1.07% from the previous period, with an average of 10,432 circulating shares per person, an increase of 1.08% [2] - Major institutional shareholders include Huabao Zhongzheng Medical ETF, Yifangda Growth Enterprise Board ETF, and Southern Zhongzheng 500 ETF, with increases in their holdings compared to the previous period [3] Market Activity - On September 1, 2023, Opcon Vision's stock price was 18.42 yuan per share, with a trading volume of 165 million yuan and a turnover rate of 1.36%, leading to a total market capitalization of 16.507 billion yuan [1] - The stock has experienced a 60-day increase of 18.76%, contrasting with recent declines over shorter periods [1]

Core Viewpoint - The stock of Opcon Vision has experienced a decline in recent trading sessions, with a notable drop of 3.61% year-to-date and 5.40% over the last five trading days, indicating potential concerns among investors regarding the company's performance and market conditions [1][2]. Financial Performance - For the first half of 2025, Opcon Vision reported a revenue of 871 million yuan, reflecting a year-on-year decrease of 1.42%. The net profit attributable to shareholders was 250 million yuan, down 22.93% compared to the previous year [2]. - Since its A-share listing, the company has distributed a total of 897 million yuan in dividends, with 526 million yuan distributed over the last three years [3]. Shareholder and Market Activity - As of August 20, 2025, the number of shareholders for Opcon Vision was 64,100, a decrease of 1.07% from the previous period. The average number of circulating shares per shareholder increased by 1.08% to 10,432 shares [2]. - The stock's trading activity showed a net outflow of 28.29 million yuan from major funds, with significant selling pressure observed [1]. Business Overview - Opcon Vision, established on October 26, 2000, and listed on January 17, 2017, specializes in the research, production, and sales of optical products and related services. Its revenue composition includes hard contact lenses (40.86%), other optical products and technical services (21.52%), medical services (19.89%), nursing products (12.57%), non-optical products (4.60%), and other supplementary products (0.55%) [1]. - The company operates within the pharmaceutical and biological industry, specifically in the medical device and consumables sector, and is associated with concepts such as ophthalmology, medical devices, smart healthcare, and health initiatives [1]. Institutional Holdings - As of June 30, 2025, notable institutional shareholders include Huabao Zhongzheng Medical ETF, Yifangda Growth Enterprise Board ETF, and Southern Zhongzheng 500 ETF, with increases in their respective holdings [3].

证券日报网讯 欧普康视8月27日在互动平台回答投资者提问时表示，公司原为硬性接触镜研发生产企 业，在这个领域始终保持领先。阿托品为药品，药品企业率先开发是正常的，公司是在非药品企业中较 早涉入阿托品滴眼液开发的企业。 （编辑 王雪儿） ...